Hansa Biopharma AB (publ) (FRA:24H)
3.270
+0.348 (11.91%)
At close: Jan 23, 2026
Hansa Biopharma AB Employees
Hansa Biopharma AB had 133 employees as of September 30, 2025. The number of employees decreased by 2 or -1.48% compared to the same quarter last year.
Employees
133
Change
-2
Growth
-1.48%
Revenue / Employee
€121,471
Profits / Employee
€436,026
Market Cap
356.82M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 133 | -2 | -1.48% |
| Jun 30, 2025 | 140 | -6 | -4.11% |
| Mar 31, 2025 | 138 | -28 | -16.87% |
| Dec 31, 2024 | 135 | -33 | -19.64% |
| Sep 30, 2024 | 135 | -33 | -19.64% |
| Jun 30, 2024 | 146 | -16 | -9.88% |
| Mar 31, 2024 | 166 | 7 | 4.40% |
| Dec 31, 2023 | 168 | 18 | 12.00% |
| Sep 30, 2023 | 168 | 23 | 15.86% |
| Jun 30, 2023 | 162 | 17 | 11.72% |
| Mar 31, 2023 | 159 | 18 | 12.77% |
| Dec 31, 2022 | 150 | 19 | 14.50% |
| Sep 30, 2022 | 145 | 18 | 14.17% |
| Jun 30, 2022 | 145 | 32 | 28.32% |
| Mar 31, 2022 | 141 | 40 | 39.60% |
| Dec 31, 2021 | 131 | 44 | 50.57% |
| Sep 30, 2021 | 127 | 47 | 58.75% |
| Jun 30, 2021 | 113 | 35 | 44.87% |
| Mar 31, 2021 | 101 | 23 | 29.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ÜSTRA Hannoversche Verkehrsbetriebe Aktiengesellschaft | 2,500 |
| SIMONA Aktiengesellschaft | 1,864 |
| Novabase S.G.P.S. | 1,281 |
| centrotherm international AG | 748 |
| Allane SE | 703 |
| Wild Bunch AG | 102 |
| EUWAX Aktiengesellschaft | 84 |
| Sino AG | 24 |
Hansa Biopharma AB News
- 6 weeks ago - Hansa Biopharma AB: Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation - Finanz Nachrichten
- 6 weeks ago - Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation - PRNewsWire
- 2 months ago - Hansa Biopharma AB (publ) (HNSBF) Discusses Phase III Trial Data and Developments in IgG-Cleaving Platform for Kidney Transplantation and Autoimmune Diseases Transcript - Seeking Alpha
- 2 months ago - Hansa Biopharma AB (publ) (HNSBF) Discusses Phase III Trial Data and Developments in IgG-Cleaving Platform for Kidney Transplantation and Autoimmune Diseases - Slideshow - Seeking Alpha
- 3 months ago - Hansa Biopharma AB (publ) 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Hansa Biopharma AB (publ) (HNSBF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Hansa Biopharma AB (HNSBF) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst Revenue ... - GuruFocus
- 3 months ago - Q3 2025 Hansa Biopharma AB Earnings Call Transcript - GuruFocus